These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 32270905)
1. Estriol serum levels in new and chronic users of vaginal estriol cream: A prospective observational study. Te West NID; Day RO; Hiley B; White C; Wright M; Moore KH Neurourol Urodyn; 2020 Apr; 39(4):1137-1144. PubMed ID: 32270905 [TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of estriol vary widely after application of vaginal oestriol cream. Te West N; Day R; Graham G; Wright M; White C; Popovic G; Moore KH Br J Clin Pharmacol; 2021 May; 87(5):2354-2360. PubMed ID: 33129232 [TBL] [Abstract][Full Text] [Related]
3. The effect of 12 weeks of estriol cream on stress urinary incontinence post-menopause: A prospective multinational observational study. Te West NID; Harris K; Jeffrey S; de Nie I; Parkin K; Roovers JP; Moore KH Neurourol Urodyn; 2023 Apr; 42(4):799-806. PubMed ID: 36840920 [TBL] [Abstract][Full Text] [Related]
4. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief? Stute P Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484 [TBL] [Abstract][Full Text] [Related]
5. [Postmenopausal vaginal atrophy and topical therapy with an estriol-based ointment (Colpogyn): authors' experience]. Oliva FA; Saltarelli E; D'Antonio GD; Mazzatenta E Minerva Ginecol; 1991 Dec; 43(12):605-7. PubMed ID: 1819780 [TBL] [Abstract][Full Text] [Related]
6. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study. Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208 [TBL] [Abstract][Full Text] [Related]
7. The Effect of Vaginal Oestriol Cream on Subjective and Objective Symptoms of Stress Urinary Incontinence and Vaginal Atrophy: An International Multi-Centre Pilot Study. Weber MA; Lim V; Oryszczyn J; Te West N; Souget J; Jeffery S; Roovers JP; Moore KH Gynecol Obstet Invest; 2017; 82(1):15-21. PubMed ID: 26990867 [TBL] [Abstract][Full Text] [Related]
8. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Barentsen R; van de Weijer PH; Schram JH Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):73-80. PubMed ID: 9031963 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. Chen J; Geng L; Song X; Li H; Giordan N; Liao Q J Sex Med; 2013 Jun; 10(6):1575-84. PubMed ID: 23574713 [TBL] [Abstract][Full Text] [Related]
10. Effects of ultralow topical estriol dose on vaginal health and quality of life in postmenopausal women who underwent surgical treatment for pelvic organ prolapse. Caruso S; Cianci S; Vitale SG; Matarazzo MG; Amore FF; Cianci A Menopause; 2017 Aug; 24(8):900-907. PubMed ID: 28350758 [TBL] [Abstract][Full Text] [Related]
11. A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women. Mattsson LA; Cullberg G Acta Obstet Gynecol Scand; 1983; 62(5):397-401. PubMed ID: 6421083 [TBL] [Abstract][Full Text] [Related]
12. Vaginal absorption of two estriol preparations. A comparative study in postmenopausal women. Mattsson LA; Cullberg G Acta Obstet Gynecol Scand; 1983; 62(5):393-6. PubMed ID: 6421082 [TBL] [Abstract][Full Text] [Related]
13. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel. Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974 [TBL] [Abstract][Full Text] [Related]
14. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women. Luengratsameerung S; Panyakhamlerd K; Treratanachat S; Taechakraichana N Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801 [TBL] [Abstract][Full Text] [Related]
15. A randomized, multiple-dose parallel study to compare the pharmacokinetic parameters of synthetic conjugated estrogens, A, administered as oral tablet or vaginal cream. Bhamra RK; Margolis MB; Liu JH; Hendy CH; Jenkins RG; DiLiberti CE Menopause; 2011 Apr; 18(4):393-9. PubMed ID: 21107298 [TBL] [Abstract][Full Text] [Related]
16. [Transvaginal administration of estriol in postmenopausal urogynecological disorders]. Di Stefano L; Patacchiola F; Moscarini M Minerva Ginecol; 1993 Nov; 45(11):551-6. PubMed ID: 8121603 [TBL] [Abstract][Full Text] [Related]
17. The estradiol vaginal ring--a study of existing clinical data. Bachmann G Maturitas; 1995 Dec; 22 Suppl():S21-9. PubMed ID: 8775773 [TBL] [Abstract][Full Text] [Related]
18. Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Biglia N; Peano E; Sgandurra P; Moggio G; Panuccio E; Migliardi M; Ravarino N; Ponzone R; Sismondi P Gynecol Endocrinol; 2010 Jun; 26(6):404-12. PubMed ID: 20196634 [TBL] [Abstract][Full Text] [Related]
19. [Climacteric syndrome: comparison of several secondary therapies]. Bianco V; Colombo A; Tassan Simonat P Ann Ostet Ginecol Med Perinat; 1991; 112(1):54-60. PubMed ID: 1929099 [TBL] [Abstract][Full Text] [Related]